The selection of celebrity physician Dr. Mehmet Oz to lead the Centers for Medicare & Medicaid Services (CMS) under a new Trump administration heralds a potentially transformative shift in American healthcare policy, focusing heavily on expanding Medicare Advantage and an unspecific plan to replace the Affordable Care Act (ACA). This move has ignited concerns among patient advocates, hospitals, and medical professionals about the future of traditional Medicare, care access, and the financial stability of the healthcare system.
President-elect Donald Trump has tapped Dr. Mehmet Oz, the well-known celebrity physician and TV personality, to serve as the administrator of CMS. This pivotal role places Oz at the helm of an agency that provides healthcare coverage to over 160 million Americans through programs like Medicare, Medicaid, and the Children’s Health Insurance Program.
The Vision for Medicare: From Traditional to Privatized
At the core of Dr. Oz’s healthcare philosophy, heavily aligned with the Trump administration’s agenda, is a significant push towards expanding Medicare Advantage (MA). During his past Senate campaign, Oz championed a “Medicare Advantage for all” plan, articulating his belief that these private plans offer quality care, are popular with seniors, and incentivize cost-efficiency. This aligns with the conservative policy blueprint, Project 2025, which proposes making Medicare Advantage the “default enrollment” for newly eligible seniors, with a long-term goal to fully displace traditional Medicare.
The proposed changes extend beyond new enrollees. Reports from sources within CMS and on Capitol Hill suggest that multiple pilot projects are being developed. These initiatives, potentially using variations of the “geographic direct contracting model” previously explored by the Trump administration, aim to:
- Make Medicare Advantage the default enrollment for newly eligible seniors.
- Transition a percentage of current traditional Medicare enrollees into Medicare Advantage plans.
- Automatically assign existing Medicare enrollees in certain counties to MA-like plans.
These pilot projects could be scaled nationwide without direct congressional oversight if Dr. Oz, as administrator, deems them “successful.” Critics, however, fear that assessments will be biased, ignoring data that indicates MA drives up costs and harms patients, in favor of metrics that facilitate privatization.
The Controversies and Consequences of Medicare Advantage
While proponents like Dr. Oz tout Medicare Advantage for its cost-saving potential and comprehensive benefits, the program has faced intense scrutiny. Insurers, led by major players like UnitedHealthcare, profit significantly by administering Medicare benefits. Already receiving over half of Medicare’s $840 billion budget, these private entities are accused of prioritizing profits over patient care through systemic denials and delays.
Key concerns surrounding Medicare Advantage include:
- Care Denials and Delays: MA plans frequently utilize a pre-authorization process, often automated and increasingly powered by artificial intelligence (AI), to approve care *before* it’s provided. This has led to widespread denials of medically necessary treatments, forcing 3.5 million seniors to pay out-of-pocket or forgo care entirely, according to a report by the Office of Inspector General.
- Financial Burden on Hospitals: Rural and urban hospitals alike report struggling with growing denial rates, time-consuming appeals, and underpayments from MA plans compared to traditional Medicare. A study by the American Hospital Association found that commercial insurer policies, including MA, are a primary factor behind rural hospital closures, with nearly 4 in 5 rural clinicians reporting higher administrative tasks and negative impacts on patient outcomes.
- Increased Costs for Taxpayers: Despite claims of efficiency, the Medicare Payment Advisory Commission (MedPAC), the program’s watchdog, reported that Medicare Advantage plans cost taxpayers 22 percent more than traditional Medicare, projected to reach $83 billion in 2024.
- Physician Burnout: The pre-authorization process is a significant driver of physician burnout, with doctors spending an estimated two hours on bureaucratic wrangling for every hour with patients, as highlighted in a poll by the American Medical Association (AMA).
- Deceptive Marketing: Seniors are often enticed by aggressive marketing campaigns, some even AARP-branded, that highlight supplemental benefits without fully disclosing downsides like restricted provider networks, out-of-pocket costs, or AI-based denial systems.
These issues have created a growing chasm between the insurance industry and organized medicine. The AMA has urged measures to curb MA underpayments and reduce prior authorizations, even suggesting the expansion of programs to import international doctors to address the deepening crisis.
Lobbying Power and Unlikely Alliances
The expansion of Medicare Advantage has been fueled by immense lobbying power. The six largest health insurers have dramatically increased their lobbying budgets, spending over $50 million annually on general lobbying, in addition to millions more on political campaigns. This financial influence helps shape policy and ensures continued growth for the private insurance sector.
Notably, the AARP, a prominent advocacy group for seniors, has been a long-standing ally of the Medicare Advantage industry. Income from UnitedHealthcare alone constitutes more than two-thirds of AARP’s marketing revenue, amounting to nearly $700 million. This partnership highlights the complex financial and political landscape influencing healthcare policy.
However, the mounting problems with Medicare Advantage are forging unlikely alliances. Republican Senator Chuck Grassley of Iowa, previously an MA supporter, has initiated an investigation into UnitedHealthcare’s billing practices, prompted by reports of overcharging the government for “ghost care” while denying necessary treatments. This suggests a bipartisan recognition of the systemic issues within the program.
The Fate of the Affordable Care Act Under Oz and Trump
Beyond Medicare, Dr. Oz’s role at CMS will also involve navigating the future of the Affordable Care Act (ACA). While Trump has consistently vowed to repeal and replace Obamacare, specific details of a new plan have remained elusive. In an interview, Oz confirmed that President Trump has a plan but did not offer specifics, referring vaguely to past proposals that “fell out.”
The discussion around the ACA is particularly timely as open enrollment for 2026 plans begins. More than 24 million people obtained coverage through the ACA marketplace in 2025, according to government data. However, enhanced subsidies, which significantly lowered premiums and were extended through 2025 by the Inflation Reduction Act, are set to expire at the end of the year. This expiration is projected to cause average out-of-pocket premium payments to double, with nearly 4 million people expected to drop coverage if the subsidies are not extended, as projected by the Congressional Budget Office (CBO) and an analysis from the KFF health policy research group.
Dr. Oz has criticized Democrats for “holding the entire country hostage” by linking government reopening to the extension of ACA subsidies. He maintains that the ACA “has been sick from the moment it was created” and that the real challenge lies in restructuring the entire healthcare system.
Broader Implications for U.S. Healthcare
Dr. Oz’s confirmation and the aggressive push for Medicare Advantage have profound long-term implications for the entire U.S. healthcare system. Advocates for universal healthcare view traditional Medicare as a vital pathway to a single-payer system. Its erosion through privatization threatens to eliminate this option, leaving “Medicare Advantage for all” as the dominant, insurer-controlled model.
As CMS Administrator, Oz would also oversee Medicaid, the safety-net program covering over 1 in 5 Americans, and the Medicare drug price negotiations established under the Inflation Reduction Act. His stated focus on cutting “waste and fraud” and incentivizing “disease prevention” will shape these programs, potentially through measures like adding work requirements for Medicaid beneficiaries and cracking down on state “financing gimmicks.”
The nomination of Dr. Oz, a figure who previously promoted unproven COVID-19 theories, has drawn mixed reactions in the Senate. While Republicans like Senator Lindsey Graham and Senator Bill Cassidy express support, citing his medical background, Democrats like Senator Sheldon Whitehouse and Senator Tim Kaine have raised concerns about his credibility and lack of relevant experience.
